Publications - 'P'
Publications 1951 - 1975 de 2458
| Titre | DOI |
|---|---|
|
Prognostic and therapeutic biomarkers in a series of 33 pediatric chordomas A. Tauziede-Espariat; K. Beccaria; F. Monnieni; H. Adle-Biassette; J. Masliah-Planchon; M. Polivka; A. Laquerriere; S. Bouillot-Eimer; G. Gauchotte; H. Sevestre; S. Puget; P. Varlet 2016 |
|
|
Prognostic and therapeutic factors of gliosarcoma from a multi-institutional series J. Castelli; L. Feuvret; Q.C. Haoming; J. Biau; E. Jouglar; A. Berger; G. Truc; L. Gutierrez; X. Morandi; P.J. Le Reste; F. Thillays; D. Loussouarn; E. Nouhaud; G. Crehange; D. Antoni; E. Vauleon; R. de Crevoisier; G. Noel 2016 |
10.1007/s11060-016-2142-9 |
|
Prognostic and Therapeutic Markers in Chordomas: A Study of 287 Tumors A. Tauziede-Espariat; D. Bresson; M. Polivka; S. Bouazza; F. Labrousse; E. Aronica; J.L. Pretet; F. Projetti; P. Herman; H. Salle; F. Monnien; S. Valmary-Degano; A. Laquerriere; M. Pocard; L. Chaigneau; N. Isambert; M.H. Aubriot-Lorton; L. Feuvret; B. George; S. Froelich; H. Adle-Biassette 2016 |
10.1093/jnen/nlv010 |
|
Prognostic Decision Making to Extend a Platform Useful Life under Service Constraint N. Herr; J.M. Nicod; C. Varnier 2014 |
|
|
Prognostic Decision Making to Extend a Platform Useful Life under Service Constraint N. Herr; J.M. Nicod; C. Varnier 2014 |
|
|
Prognostic Effect of BRAF and KRAS Mutations in Patients With Stage III Colon Cancer Treated With Leucovorin, Fluorouracil, and Oxaliplatin With or Without Cetuximab A Post Hoc Analysis of the PETACC-8 Trial J. Taieb; A. Zaanan; K. Le Malicot; C. Julie; H. Blons; L. Mineur; J. Bennouna; J. Tabernero; E. Mini; G. Folprecht; J.Luc Van Laethem; C. Lepage; J.F. Emile; P. Laurent-Puig 2016 |
10.1001/jamaoncol.2015.5225 |
|
Prognostic factor analysis for elderly patients treated for metastatic colorectal cancer in the randomized phase II trial PRODIGE 20 T. Aparicio; O. Bouche; E. Francois; E. Maillard; S. Kirscher; J. Taieb; P.L. Etienne; R. Faroux; K. Akouz; E. Hajbi; C. Locher; Y. Rinaldi; T. Lecomte; S. Lavau-Denes; M. Baconnier; A. Oden-Gangloff; D. Genet; E. Paillaud; F. Retornaz; L. Bedenne 2016 |
10.1093/annonc/mdw370.131 |
|
Prognostic factors and patterns of recurrence after emergency management for obstructing colon cancer: multivariate analysis from a series of 2120 patients G. Manceau; T. Voron; D. Mege; V. Bridoux; Z. Lakkis; A. Venara; L. Beyer-Berjot; S. Abdalla; I. Sielezneff; J.H. Lefevre; M. Karoui; T. Codjia; M. Dazza; G. Gagnat; S. Hamel; L. Mallet; P. Martre; G. Philouze; E. Roussel; P. Tortajada; A.S. Dumaine; B. Heyd; B. Paquette; F. Brunetti; F. Esposito; V. Lizzi; N. Michot; Q. Denost; C. Tresallet; O. Tetard; J.M. Regimbeau; C. Sabbagh; P. Rivier; E. Fayssal; M. Collard; D. Moszkowicz; R. Lupinacci; F. Peschaud; J.C. Etienne; L. Loge; T. Bege; H. Corte; E. D'Annunzio; M. Humeau; J. Issard; N. Munoz; J. Abba; Y. Jafar; L. Lacaze; P.Y. Sage; L. Susoko; B. Trilling; C. Arvieux; F. Mauvais; B. Ulloa-Severino; S. Pitel; V. de Chaumont; B. Badic; B. Blanc; M. Bert; P. Rat; P. Ortega-Deballon; A. Chau; C. Dejeante; G. Piessen; E. Gregoire; A. Alfarai; M. Cabau; A. David; D. Kadoche; F. Dufour; G. Goin; Y. Goudard; G. Pauleau; P. Sockeel; B. De la Villeon; K. Pautrat; C. Eveno; A. Brouquet; S. Abdalla; A.C. Couchard; G. Balbo; J.Y. Mabrut; J. Bellinger; M. Bertrand; A. Aumont; E. Duchalais; A.S. Messiere; A. Tranchart; J.B. Cazauran; V. Pichot-Delahaye; V. Dubuisson; L. Maggiori; B. Djawad-Boumediene; D. Fuks; X. Kahn; E. Huart; J.M. Catheline; G. Lailler; O. Baraket; P. Baque; J.M.Diaz de Cerio; P. Mariol; B. Maes; P. Fernoux; P. Guillem; E. Chatelain; deSaint Roman; K. Fixot; Y. Parc; A.F.C.French Sur Grp 2019 |
10.1007/s00423-019-01819-5 |
|
Prognostic Factors for Local Control in Breast Cancer After Long-term Follow-up in the EORTC Boost vs No Boost Trial A Randomized Clinical Trial C. Vrieling; E. van Werkhoven; P. Maingon; P. Poortmans; C. Weltens; A. Fourquet; D. Schinagl; B. Oei; C.C. Rodenhuis; J.C. Horiot; H. Struikmans; E. Van Limbergen; Y. Kirova; P. Elkhuizen; R. Bongartz; R. Miralbell; D.A.L. Morgan; J.B. Dubois; V. Remouchamps; R.O. Mirimanoff; G. Hart; S. Collette; L. Collette; H. Bartelink; E.Org Res Tr Gr; R.Oncology B. Grp 2017 |
10.1001/jamaoncol.2016.3031 |
|
Prognostic factors for survival in adult patients with recurrent glioblastoma: a decision-tree-based model E. Audureau; A. Chivet; R. Ursu; R. Corns; P. Metellus; G. Noel; S. Zouaoui; J. Guyotat; P.J. Le Reste; T. Faillot; F. Litre; N. Desse; A. Petit; E. Emery; E. Lechapt-Zalcman; J. Peltier; J. Duntze; E. Dezamis; J. Voirin; P. Menei; F. Caire; P.Dam Hieu; J.L. Barat; O. Langlois; J.R. Vignes; P. Fabbro-Peray; A. Riondel; E. Sorbets; M. Zanello; A. Roux; A. Carpentier; L. Bauchet; J. Pallud; C.NeuroOnco Francaise 2018 |
10.1007/s11060-017-2685-4 |
|
Prognostic Factors for Survival in Noncastrate Metastatic Prostate Cancer: Validation of the Glass Model and Development of a Novel Simplified Prognostic Model G. Gravis; J.M. Boher; K. Fizazi; F. Joly; F. Priou; P. Marino; I. Latorzeff; R. Delva; I. Krakowski; B. Laguerre; J. Walz; F. Rolland; C. Theodore; G. Deplanque; J.M. Ferrero; D. Pouessel; L. Mourey; P. Beuzeboc; S. Zanetta; M. Habibian; J.F. Berdah; J. Dauba; M. Baciuchka; C. Platini; C. Linassier; J.L. Labourey; J.Pascal Machiels; C.El Kouri; A. Ravaud; E. Suc; J.C. Eymard; A. Hasbini; G. Bousquet; M. Soulie; S. Oudard 2015 |
10.1016/j.eururo.2014.09.022 |
|
Prognostic factors in patients treated with second-line chemotherapy for advanced gastric cancer: results from the randomized prospective phase III FFCD-0307 trial Y. Touchefeu; R. Guimbaud; C. Louvet; L. Dahan; E. Samalin; E. Barbier; K. Le Malicot; R. Cohen; J.M. Gornet; T. Aparicio; S. Nguyen; A. Azzedine; P.L. Etienne; J.M. Phelip; P. Hammel; N. Chapelle; D. Sefrioui; L. Mineur; C. Lepage; O. Bouche 2019 |
10.1007/s10120-018-0885-z |
|
Prognostic factors of good response to DMARDs in psoriatic arthritis: a narrative review C. Mekhail; M. Chouk; C. Prati; D. Wendling; F. Verhoeven 2020 |
10.1080/17512433.2020.1758556, Early Access Date = {MAY 2020 |
|
Prognostic factors of good response to DMARDs in psoriatic arthritis: a narrative review C. Mekhail; M. Chouk; C. Prati; D. Wendling; F. Verhoeven 2020 |
10.1080/17512433.2020.1758556 |
|
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neo-adjuvant chemotherapy followed by interval debulking surgery: A multicenter cohort analysis from the FRANCOGYN study group L. Vincent; C. Jankowski; L. Ouldamer; M. Ballester; S. Bendifallah; P.A. Bolze; C. Akladios; H. Costaz; V. Lavoue; G. Canlorbe; P. Collinet; C. Touboul; C. Huchon; A. Bricou; S. Dridi; M.M. Padeano; L. Bengrine; L. Arnould; C. Coutant; G.Rech FRANCOGYN 2020 |
10.1016/j.ejso.2020.04.029 |
|
Prognostic factors of overall survival for patients with FIGO stage IIIc or IVa ovarian cancer treated with neoadjuvant chemotherapy followed by interval debulking surgery L. Vincent; C. Jankowski; L. Ouldamer; M. Ballester; S. Bendifallah; P.A. Bolze; C. Akladios; H. Costaz; V. Lavoue; C. Uzan; P. Collinet; C. Touboul; C. Huchon; A. Bricou; S. Dridi; M.M. Padeano; J. Fraisse; L. Bengrine; L. Arnould; C. Coutant 2019 |
10.1200/JCO.2019.37.15_suppl.e17060 |
|
Prognostic Factors of Survival among Women with Metastatic Breast Cancer and Impact of Primary or Secondary Nature of Disease on Survival: A French Population-Based Study E.M. Marshall; A. Bertaut; I. Desmoulins; A. Darut-Jouve; T. Ponnelle; M.L. Poillot; F. Beltjens; P. Arveux 2017 |
10.1111/tbj.12717 |
|
Prognostic factors of survival in HIV/HCV co-infected patients with hepatocellular carcinoma: The CARCINOVIC Cohort M. Gelu-Simeon; M. Lewin; M. Ostos; T. Bayan; M.Beso Delgado; E. Teicher; R. Layese; F. Roudot-Thoraval; H. Fontaine; R. Sobesky; D. Salmon-Ceron; D. Samuel; O. Seror; P. Nahon; L. Meyer; J.C. Duclos-Vallee; V. Petrov-Sanchez; B. Autran; F. Boufassa; M. Bourliere; S. Dominguez; C. Hezode; G.P. Pageaux; I. Poizot-Martin; A.M. Roque-Afonso; A. Samri; D. Vittecoq; T. Allegre; V. Di Martino; E. Muel; V. de Ledinghen; E. Germain; W. Merouche; P. Morlat; F. Bonnet; J. Delaune; S. Caldato; C. Chesnel; L. Piroth; S. Gohier; P. Crenn; H. Berthe; J.–P. Zarski; V. Leroy; Z. Baidi; P. Miailhes; S. Ogoudjob; I. Poizot–Martin; A. Ivanova; D. Botta; C. Ansaldi; G.Philippe Pageaux; P. Rocher; A. Tran; R. Anty; A. Gervais; C. Godart; E. Papot; D. Salmon; P. Guet; F. Andre; J.B. Trabut; L. Bousquet; D. Batisse; L. Collias; A. Simon; E. Bourzam; C. Lupin; M.A. Valantin; D. Beniken; K. Lacombe; P. Campa; J.Luc Lagneau; O. Chazouilleres; K.Belkhir Hadid; D. Ponscarme; G. Pialoux; J. Chas; N. Velazquez; D. Guyader; I. Renard; P. Tattevin; M. Ratajczak; D. Zucman; D. Bonarel; L. Alric; Y. Yazdanpanah; K. Amrani; M. Ould-Rabah; M. Gelu-Simeon; M.Grazia Tateo; T.Maria Antonini; A. Coilly; B. Roche; E. De Martin; M. Belnard; I. Ogier; E. Salame; C. Dumontet; C. Piat; M. Debette-Gratien; B. Randrianarivo; A. Lefevre; D. Salmon; F. Dabis; M. Winnock; M.A. Loko; P. Sogni; Y. Benhamou; P. Trimoulet; J. Izopet; V. Paradis; B. Spire; P. Carrieri; C. Katlama; G. Pialoux; M.A. Valantin; P. Bonnard; I. Poizot-Martin; B. Marchou; E. Rosenthal; D. Garipuy; O. Bouchaud; A. Gervais; C. Lascoux-Combe; C. Goujard; K. Lacombe; C. Duvivier; D. Vittecoq; D. Neau; P. Morlat; F. BaniSadr; L. Meyer; F. Boufassa; S. Dominguez; B. Autran; A.M. Roque; C. Solas; H. Fontaine; L. Serfaty; G. Chene; D. Costagliola; D. Zucman; A. Simon; S. Dominguez; E. Billaud; P. Miailhes; P. Devoto; S. Couffin-Cadiergues; F. Dabis; L. Wittkop; P. Nahon; V. Mahuas-Bourcier; J. Zucman-Rossi; P. Bedossa; A. Laurent; R. Layese; I. Durand-Zaleski; P. Marche; V. Thibault; H. Fontaine; D. Guyader; S. Dharancy; V. Leroy; V. Vilgrain; M. Bonjour; C. Cagnot; V. Petrov-Sanchez; N. Ganne-Carrie; V. Bourcier; S. Pol; O. Rosmorduc; D. Roulot; D. Furand; A. Mallat; P. Attali; J.D. Grange; E. Nguyen; P. Cales; M. Bourliere; J.P. Bronowicki; A. Tran; F. Mal; C. Christidis; C. Silvain; C. Wartelle; V. Di Martino; V. De Ledinghen; J.F. Blanc; F. Zoulim; P. Merle; A. Abergel; S. Hillaire; T. Dao; P. Mathurin; C. Pilette; J.P. Zarski; D. Larrey; G. Thiefin; O. Goria; G. Riachi; D. Ouzan; J.M. Peron; L. Alric; T. Lecomte; A.N.R.S.H.C.E.P. 25 P. Grp; A.N.R.S.C.O.13 H.E.P.A.V. Grp; A.N.R.S.C.O.12 CirVi Grp 2019 |
10.1111/liv.13921 |
|
PROGNOSTIC HETEROGENEITY AMONG HIGH RISK MULTIPLE MYELOMA PATIENTS (T(4-14) AND DEL17P) ACCORDING TO ADDITIONAL CYTOGENETIC ABNORMALITIES, THE IFM EXPERIENCE H. Benjamin; M. Florence; C. Alice; L.C. Valerie; C. Marie-Lorraine; H. Cyrille; L. Xavier; M. Gerald; K. Lionel; R. Murielle; R. Philippe; S. Catherine; L. Francois; B. Sabine; A. Marie; W. Marc; O.P. Frederique; C. Sylvie; L. Gerard; P. Brrigitte; B. Karim; F. Jean; V. Laurent; G. Laurent; R. Bruno; D. Mamoun; M. Margaret; C. Denis; M. Mohamad; F. Thierry; M. Philippe; A. Michel; C. Jill; M. Stephane; A.L. Herve 2014 |
|
|
PROGNOSTIC HETEROGENEITY AMONG HIGH RISK MULTIPLE MYELOMA PATIENTS (T(4-14) AND DEL17P) ACCORDING TO ADDITIONAL CYTOGENETIC ABNORMALITIES, THE IFM EXPERIENCE H. Benjamin; M. Florence; C. Alice; L.C. Valerie; C. Marie-Lorraine; H. Cyrille; L. Xavier; M. Gerald; K. Lionel; R. Murielle; R. Philippe; S. Catherine; L. Francois; B. Sabine; A. Marie; W. Marc; O.P. Frederique; C. Sylvie; L. Gerard; P. Brrigitte; B. Karim; F. Jean; V. Laurent; G. Laurent; R. Bruno; D. Mamoun; M. Margaret; C. Denis; M. Mohamad; F. Thierry; M. Philippe; A. Michel; C. Jill; M. Stephane; A.L. Herve 2014 |
|
|
PROGNOSTIC HETEROGENEITY AMONG HIGH RISK MULTIPLE MYELOMA PATIENTS (T(4-14) AND DEL17P) ACCORDING TO ADDITIONAL CYTOGENETIC ABNORMALITIES, THE IFM EXPERIENCE H. Benjamin; M. Florence; C. Alice; L.C. Valerie; C. Marie-Lorraine; H. Cyrille; L. Xavier; M. Gerald; K. Lionel; R. Murielle; R. Philippe; S. Catherine; L. Francois; B. Sabine; A. Marie; W. Marc; O.P. Frederique; C. Sylvie; L. Gerard; P. Brrigitte; B. Karim; F. Jean; V. Laurent; G. Laurent; R. Bruno; D. Mamoun; M. Margaret; C. Denis; M. Mohamad; F. Thierry; M. Philippe; A. Michel; C. Jill; M. Stephane; A.L. Herve 2014 |
|
|
Prognostic Impact of 1st-Line Treatment and Molecular Testing in Advanced NSCLC in France - Results of the IFCT-PREDICT.amm Study J. Cadranel; E. Quoix; M. Duruisseaux; S. Friard; M. Wislez; C. Danie; E. Fabre; A. Madroszyk; V. Westeel; P. Merle; H. Lena; E. Dansin; J. Mazieres; A. Scherperee; S. Hiret; C. Kaderbhai; P.J. Souquet; P. Missy; A. Langlais; F. Morin; G. Zalcman; D. Moro-Sibilot; F. Barlesi 2017 |
|
|
Prognostic Impact of 1st-Line Treatment and Molecular Testing in Advanced NSCLC in France - Results of the IFCT-PREDICT.amm Study J. Cadranel; E. Quoix; M. Duruisseaux; S. Friard; M. Wislez; C. Danie; E. Fabre; A. Madroszyk; V. Westeel; P. Merle; H. Lena; E. Dansin; J. Mazieres; A. Scherperee; S. Hiret; C. Kaderbhai; P.J. Souquet; P. Missy; A. Langlais; F. Morin; G. Zalcman; D. Moro-Sibilot; F. Barlesi 2017 |
10.1016/j.jtho.2016.11.1318 |
|
Prognostic Impact of Asymptomatic Carotid Artery Stenosis in Patients Undergoing Coronary Artery Bypass Grafting G. Santarpino; F. Nicolini; M. De Feo; M. Dalen; T. Fischlein; A. Perrotti; D. Reichart; G. Gatti; F. Onorati; I. Franzese; G. Faggian; C. Bancone; S. Chocron; S. Khodabandeh; A.S. Rubino; D. Maselli; S. Nardella; R. Gherli; A. Salsano; M. Zanobini; M. Saccocci; K. Bounader; S. Rosato; T. Tauriainen; G. Mariscalco; J. Airaksinen; V.G. Ruggieri; F. Biancari 2018 |
10.1016/j.ejvs.2018.07.042 |
|
Prognostic impact of EBV serostatus in patients with lymphomas or chronic malignancies undergoing allogeneic HCT J. Styczynski; G. Tridello; L. Gil; P. Ljungman; M. Mikulska; K.N. Ward; C. Cordonnier; R. de la Camara; D. Averbuch; N. Knelange; G. Socie; P. Chevallier; D. Blaise; I. Yakoub-Agha; E. Forcade; J. Cornelissen; J. Maertens; E. Petersen; S. Nguyen-Quoc; H. Veelken; N. Schaap; J. Passweg; M. Michallet; N. Fegueux; E. Deconinck; N. Russell; G. Basak; P. Bader; S. Montoto; N. Kroeger; S. Cesaro; I.Dis Workin EBMT 2019 |
10.1038/s41409-019-0627-9 |